PALO ALTO, Calif.--(BUSINESS WIRE)--Inscopix celebrates an important milestone that neuroscientists across the world using the company’s brain mapping platform have collectively achieved – more than 100 scientific publications that shed light on how brain circuits shape behavior and cognition, both in health and in disease.
Used by over 400 academic and industry laboratories, Inscopix’s miniature microscope-based brain mapping technology enables the recording and manipulation of brain activity in thousands of neurons simultaneously in freely behaving animal subjects. This unprecedented experimental capability, bolstered by a complete solution from biological reagents to data analytics to world class scientific support, has enabled key neuroscience discoveries in areas including learning and memory, sleep, and social behavior. Some of these insights have already been leveraged in translational research for many difficult-to-treat indications, including Parkinson’s disease and chronic pain.
“We are really proud of the amazing research that our customers and collaborators worldwide are pioneering. To know that our platform and solutions have helped enable more than 100 publications since the first shipment of our nVista™ product in 2013, is extremely rewarding and inspiring,” said Kunal Ghosh, Ph.D., founder and CEO of Inscopix. “We are committed to our customers’ scientific success and we look forward to helping them catalyze new breakthroughs in our mechanistic understanding of the brain.”
Inscopix will continue to celebrate this milestone throughout 2020. Congratulate the community of researchers and take part in spreading awareness about their research by following us on Facebook, LinkedIn, Instagram, YouTube and Twitter. To learn more about the technology and our recent research collaborations, visit: https://www.inscopix.com/.
About nVista™ and nVoke™ systems
nVista and nVoke systems are Inscopix’s state-of-the-art miniature microscope-based solution for imaging and manipulation of large-scale neural circuit dynamics in freely behaving subjects. With nVista and nVoke, researchers at leading research institutions worldwide are pushing the frontiers of neuroscience and asking entirely new questions about how neural circuits shape cognition and behavior in health and disease. For more information, please visit: https://www.inscopix.com/nVoke.
About Inscopix, Inc.
Inscopix empowers the development of next-generation therapeutics for difficult-to-treat brain disorders by enabling innovative research and predictive preclinical therapeutic development. Driven by a North Star of overcoming historic challenges in the field, Inscopix provides validated solutions for real-time mapping of neural activity in brain circuits. These objective, quantitative and in-brain assays are catalyzing unprecedented insights into disease mechanisms and have been shown to be more accurate at predicting clinical efficacy than animal behavior when testing a therapeutic candidate’s capacity to bring the brain back to a normal state. Inscopix’s partner and customer discoveries help decode the brain, inform deeper understanding of mechanisms of action and enable the screening of drugs based on efficacy. For more information, please visit http://www.inscopix.com.
